COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Publicis acquiert LiveRamp pour accélérer la co-création de données au service d'agents plus intelligents
Publicis acquiert LiveRamp pour accélérer la co-création de données au service d'agents plus intelligents. Le Groupe élargit son marché adressable et relève ses objectifs financiers 2027-2028 -
-
COMMUNIQUÉ DE PRESSE
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Nanobiotix presents part 1 data from JNJ-1900 (NBTXR3) in lung cancer at ESTRO 2026, showing promising responses. JNJ-1900 is a novel oncology product activated by radiotherapy -
-
COMMUNIQUÉ DE PRESSE
The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
elumeo SE postpones the publication of its audited financial statements for 2025 to 12 June 2026, expecting no significant changes. Details on ongoing audit and ESEF certification -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Onco-Innovations advances CMC program by initiating analytical method validation for ONC010 API, partnering with Dalton Pharma Services for IND-enabling studies and Phase I clinical development support -
